G Medical Innovations Holdings Ltd
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in Israel. The company's products include Prizma, a multi-sensor device that measures vital signs and generate the health trend report; and Extended Holter Patch System, a multi-channel patient-worn… Read more
Market Cap & Net Worth: G Medical Innovations Holdings Ltd (GMVDF)
G Medical Innovations Holdings Ltd (PINK:GMVDF) has a market capitalization of $51.98K ($51.98K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #48072 globally and #14799 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying G Medical Innovations Holdings Ltd's stock price $0.00 by its total outstanding shares 259918181 (259.92 Million).
G Medical Innovations Holdings Ltd Market Cap History: 2018 to 2025
G Medical Innovations Holdings Ltd's market capitalization history from 2018 to 2025. Data shows change from $11.14 Billion to $51.98K (-81.97% CAGR).
G Medical Innovations Holdings Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how G Medical Innovations Holdings Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
192.88x
G Medical Innovations Holdings Ltd's market cap is 192.88 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $11.14 Billion | $3.06 Million | -$16.98 Million | 3639.45x | N/A |
| 2019 | $8.19 Billion | $5.53 Million | -$15.51 Million | 1481.62x | N/A |
| 2020 | $20.92 Billion | $4.90 Million | -$12.54 Million | 4270.08x | N/A |
| 2021 | $15.19 Billion | $4.96 Million | -$14.76 Million | 3062.33x | N/A |
| 2022 | $852.53 Million | $4.42 Million | -$24.63 Million | 192.88x | N/A |
Competitor Companies of GMVDF by Market Capitalization
Companies near G Medical Innovations Holdings Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to G Medical Innovations Holdings Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
G Medical Innovations Holdings Ltd Historical Marketcap From 2018 to 2025
Between 2018 and today, G Medical Innovations Holdings Ltd's market cap moved from $11.14 Billion to $ 51.98K, with a yearly change of -81.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $51.98K | +100.00% |
| 2024 | $25.99K | -99.54% |
| 2023 | $5.61 Million | -99.34% |
| 2022 | $852.53 Million | -94.39% |
| 2021 | $15.19 Billion | -27.39% |
| 2020 | $20.92 Billion | +155.56% |
| 2019 | $8.19 Billion | -26.53% |
| 2018 | $11.14 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of G Medical Innovations Holdings Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $51.98K USD |
| MoneyControl | $51.98K USD |
| MarketWatch | $51.98K USD |
| marketcap.company | $51.98K USD |
| Reuters | $51.98K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.